Nevirapin-Mepha 400 mg, Retardtabletten
7680663180023
CH-66318
Tabletten
Associated product:
NEVIRAPIN Mepha cpr ret 400 mg blist 30 pce
1 / 3
google
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
nevirapinum
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
povidonum K 25
|
- | Substance | HNIDK |
|
macrogolum 7'000'000
|
- | Substance | HNIDK |
|
macrogolum 900'000
|
- | Substance | HNIDK |
|
silica colloidalis anhydrica
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 66318
- Drug name
- Nevirapin-Mepha, Retardtabletten
- Galenic form
- RETT
- ATC Code
- J05AG01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 23/11/2016
- Authorization expiration date
- 01/12/2026
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- NEVIRAPIN Mepha cpr ret 400 mg blist 30 pce
- Description (DE)
- NEVIRAPIN Mepha Ret Tabl 400 mg Blist 30 Stk
- Market launch
- 23/11/2016
- Market withdrawal
- 22/06/2026
- Narcotic (BTM)
- No
Available generics (2)
Other package sizes (1)
None
30 TABL
GTIN: None